Texas HB3785 mandates specific labeling requirements for compounded drug products.

HB3785 amends the Occupations Code to establish detailed labeling requirements for compounded drug products. These requirements apply to pharmacies and entities that compound drugs for distribution through telepharmacy services, over-the-counter sales, or directly from pharmacists to patients. Compounded drugs must be labeled with the patient's name, pharmacy details, a statement indicating the drug is a compounded substitute, all active ingredients, the beyond-use date, the quantity, and ancillary instructions including storage and cautionary statements.

Texas HB3785 mandates specific labeling requirements for compounded drug products.

HB3785 amends the Occupations Code to establish detailed labeling requirements for compounded drug products. These requirements apply to pharmacies and entities that compound drugs for distribution through telepharmacy services, over-the-counter sales, or directly from pharmacists to patients. Compounded drugs must be labeled with the patient's name, pharmacy details, a statement indicating the drug is a compounded substitute, all active ingredients, the beyond-use date, the quantity, and ancillary instructions including storage and cautionary statements.